High-dose recombinant interleukin-2/verapamil combination in advanced cancer

被引：4
|
作者：
Tagliaferri, P [1 ]
Correale, P [1 ]
Mottola, M [1 ]
deSimone, G [1 ]
Montesarchio, V [1 ]
Matano, E [1 ]
Rea, A [1 ]
Morabito, A [1 ]
Famiani, M [1 ]
Ciardiello, F [1 ]
Tortora, G [1 ]
Caraglia, M [1 ]
Barile, C [1 ]
Palmieri, G [1 ]
Bianco, AR [1 ]
机构：
[1] UNIV NAPLES FEDERICO II,IST MED INTERNA & MALATTIE DISMETAB,I-80131 NAPLES,ITALY
来源：
EUROPEAN JOURNAL OF CANCER | 1996年 / 32A卷 / 08期
关键词：
D O I：
10.1016/0959-8049(96)00126-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1436 / 1437
页数：2
相关论文
共 50 条
  • [41] Randomized study of high-dose and low-dose interleukin-2 in patients with metastatic renal cancer
    Yang, JC
    Sherry, RM
    Steinberg, SM
    Topalian, SL
    Schwartzentruber, DJ
    Hwu, P
    Seipp, CA
    Rogers-Freezer, L
    Morton, KE
    White, DE
    Liewehr, DJ
    Merino, MJ
    Rosenberg, SA
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (16) : 3127 - 3132
  • [42] A PHASE-I STUDY OF HIGH-DOSE INTERLEUKIN-2 IN COMBINATION WITH INTERFERON-ALPHA-2B
    SZNOL, M
    MIER, JW
    SPARANO, J
    GAYNOR, ER
    WEISS, GR
    MARGOLIN, KA
    BAR, MH
    HAWKINS, MJ
    ATKINS, MB
    DUTCHER, JP
    FISHER, RI
    BOLDT, DH
    DOROSHOW, JH
    LOUIE, A
    ARONSON, FR
    [J]. JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS, 1990, 9 (06): : 529 - 537
  • [43] Experience in administration of high-dose interleukin-2 immunotherapy in combination with chemotherapy for disseminated skin melanoma management
    Baranau, Y.
    Zhavrid, E.
    Petrovitch, S.
    Sachivko, N.
    Zhuravkin, I.
    [J]. EJC SUPPLEMENTS, 2009, 7 (02): : 588 - 588
  • [44] CLINICAL-RESULTS OF 2 REGIMENS WITH HIGH-DOSE AND INTERLEUKIN-2 IN ADVANCED RENAL-CELL CANCER AND MALIGNANT-MELANOMA
    FENCHEL, K
    WINKLER, A
    MITROU, PS
    HOELZER, D
    BERGMANN, L
    [J]. EUROPEAN JOURNAL OF CANCER, 1995, 31A : 52 - 52
  • [45] Can outpatient interleukin-2 and interferon replace high-dose interleukin-2 for metastatic renal cell carcinoma?
    Johannes Vieweg
    [J]. Nature Clinical Practice Oncology, 2005, 2 : 192 - 193
  • [46] Can outpatient interleukin-2 and interferon replace high-dose interleukin-2 for metastatic renal cell carcinoma?
    Vieweg, J
    [J]. NATURE CLINICAL PRACTICE ONCOLOGY, 2005, 2 (04): : 192 - 193
  • [47] High-dose interleukin-2 (HD IL-2) in the treatment of advanced melanoma: The University of Pittsburgh experience
    Davar, Diwakar
    Saul, Melissa
    Tarhini, Ahmad A.
    An Tran
    Trent, Kerry
    Sander, Cindy
    Kirkwood, John M.
    Tawbi, Hussein Abdul-Hassan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [48] Treatment of metastatic renal cancer with high-dose interleukin-2 after targeted therapy.
    Hawkins, Robert E.
    Galvis, Victoria
    Shanks, Jonathan
    Dalal, Neha
    Thistlethwaite, Fiona
    Spencer-Shaw, Andrea
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [49] Phase I trial of interleukin-2 and high-dose arginine butyrate in metastatic colorectal cancer
    J. Y. Douillard
    J. Bennouna
    F. Vavasseur
    R. Deporte-Fety
    P. Thomare
    F. Giacalone
    K. Meflah
    [J]. Cancer Immunology, Immunotherapy, 2000, 49 : 56 - 61
  • [50] HIGH-DOSE INTERLEUKIN-2 PROMOTES BACTERIAL TRANSLOCATION FROM THE GUT
    REYNOLDS, JV
    MURCHAN, P
    LEONARD, N
    GOUGH, DB
    CLARKE, P
    KEANE, FBV
    TANNER, WA
    [J]. BRITISH JOURNAL OF CANCER, 1995, 72 (03) : 634 - 636
12345